- Correction
- Open access
- Published:
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
Acta Neuropathologica Communications volume 9, Article number: 161 (2021)
The Original Article was published on 28 June 2017
Correction to: Acta Neuropathologica Communications (2017) 5:53 https://doi.org/10.1186/s40478-017-0456-2
Following publication of the original article [1], the author identified an error in Fig. 4E. The data and statistics were correct, but the synaptophysin blot was incorrect.
The incorrect (Fig. 1) and correct figure (Fig. 2) are shown in this correction article.
Incorrect version of Fig. 4E as originally published
Correct version of Fig. 4E
Reference
Finkelstein DI, Billings JL, Adlard PA et al (2017) The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease. Acta Neuropathol Commun 5:53. https://doi.org/10.1186/s40478-017-0456-2
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Finkelstein, D.I., Billings, J.L., Adlard, P.A. et al. Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease. acta neuropathol commun 9, 161 (2021). https://doi.org/10.1186/s40478-021-01258-8
Published:
DOI: https://doi.org/10.1186/s40478-021-01258-8